| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/25/2009 | WO2009046863A3 Use of thymosin alpha 1 peptide or the combination with the human pancreatic polypeptide as a therapeutic agent |
| 06/25/2009 | WO2009046299A3 Implantable drug depot for intrathecal drug delivery system for pain management |
| 06/25/2009 | WO2009040046A3 Use of stresscopin-related peptide as a therapeutic agent |
| 06/25/2009 | WO2009040021A3 Use of a peptide as a therapeutic agent |
| 06/25/2009 | WO2009033746A3 Use of a peptide as a therapeutic agent |
| 06/25/2009 | WO2008145840A3 Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of spinal cord traumas |
| 06/25/2009 | WO2008129023A3 Oligonucleotide compositions for the treatment of alzheimer's disease |
| 06/25/2009 | US20090163716 Spirocyclic cyclohexane compounds |
| 06/25/2009 | US20090163593 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists; pain, Parkinson's disease, multiple sclerosis, or Huntington's chorea; asthma |
| 06/25/2009 | US20090163580 Anti-aging composition containing resveratrol and method of administration |
| 06/25/2009 | US20090163566 Imidazole Derivatives and their use for Modulating the Gabaa Receptor Complex |
| 06/25/2009 | US20090163565 Compounds with nootropic action, their preperation, pharmaceutical compositions containing them, and use thereof |
| 06/25/2009 | US20090163561 Amorphous metaxalone and amorphous dispersions thereof |
| 06/25/2009 | US20090163556 Glycinamide derivatives as raf-kinase inhbitors |
| 06/25/2009 | US20090163552 Carboxyl- or hydroxyl-substituted benzimidazole derivatives |
| 06/25/2009 | US20090163547 Indene derivatives, their preparation and use as medicaments |
| 06/25/2009 | US20090163542 5-ht7 receptor antagonists |
| 06/25/2009 | US20090163535 Substituted Heteroarylalkanoic Acids |
| 06/25/2009 | US20090163530 adapted to adhere to and dissolve in a mouth of a consumer include a water soluble film-forming polymer pullulan, antimicrobially effective amounts of essential oils thymol, methyl salicylate, eucalyptol and menthol; for killing plaque-producing germs that cause dental plaque, bad breath, gingivitis |
| 06/25/2009 | US20090163529 Identifying therapeutic compounds based on their physical-chemical properties |
| 06/25/2009 | US20090163528 Pharmaceutical composition having analgesic effects |
| 06/25/2009 | US20090163519 Dosing regimen associated with long acting injectable paliperidone esters |
| 06/25/2009 | US20090163514 Benzisoxazole piperazine compounds and methods of use thereof |
| 06/25/2009 | US20090163508 Amide compound |
| 06/25/2009 | US20090163506 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |
| 06/25/2009 | US20090163495 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 06/25/2009 | US20090163493 cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor |
| 06/25/2009 | US20090163492 Substituted Oxindole Derivatives, Drugs Containing Said Derivatives and the Use Thereof |
| 06/25/2009 | US20090163485 Heteroaryl derivatives as orexin receptor antagonists |
| 06/25/2009 | US20090163475 Crystalline form of benzazepinium maleate derivative |
| 06/25/2009 | US20090163473 (PYRIDO/THIENO)-[f]-OXAZEPINE-5-ONE DERIVATIVES |
| 06/25/2009 | US20090163464 Benzothiazole and benzooxazole derivatives and methods of use |
| 06/25/2009 | US20090163458 Compositions and methods for treating Parkinson's disease and related disorders |
| 06/25/2009 | US20090163443 from the culture of Streptomyces vayuensis strain; Nonadeca-6-enoic acid-3-(hexadecyloxy-hydroxy-thiophosphoryloxy)-quinoxalin-2-yl ester, useful particularly for prevention of obesity and treatment of diabetes, sleep apnea, nervous system, cardiovascular and gastrointestinal disorders |
| 06/25/2009 | US20090163421 Room Temperature Stable, Lyophilized Natriuretic Peptide Formulations |
| 06/25/2009 | US20090162456 Composition and method for prevention and treatment of alzheimer's disease |
| 06/25/2009 | US20090162441 Pulmonary delivery in treating disorders of the central nervous system |
| 06/25/2009 | US20090162412 Implantable polymeric device for sustained release of dopamine agonist |
| 06/25/2009 | US20090162386 Chondrocyte therapeutic delivery system |
| 06/25/2009 | US20090162367 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 06/25/2009 | US20090162363 Pedf-r receptor and uses |
| 06/25/2009 | US20090162362 Alzheimer's disease treatment method |
| 06/25/2009 | US20090162358 Antigen binding proteins |
| 06/25/2009 | US20090162336 Novel Tools for the Diagnosis and Treatment of Alzheimer's Disease |
| 06/25/2009 | US20090162333 Pharmaceutical composition comprising apolipoproteins for the treatment of human diseases |
| 06/25/2009 | US20090162330 Method of Isolating Human Neuroepithelial Precursor Cells from Human Fetal Tissue |
| 06/25/2009 | US20090162327 Bone marrow transplantation for treatment of stroke |
| 06/25/2009 | US20090162298 Buccal, polar and non-polar spray containing sumatriptan |
| 06/25/2009 | US20090162297 Buccal, polar and non-polar spray containing ondansetron |
| 06/25/2009 | US20090162283 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| 06/25/2009 | DE102007063210A1 Arzneimittel zur Behandlung von Phantomphänomenen Drugs for treatment of phantom phenomena |
| 06/25/2009 | CA2709821A1 5-oxo-3-pyrrolidinecarboxamide derivatives as p2x7 modulators |
| 06/25/2009 | CA2709081A1 Cyclopropyl amine derivatives |
| 06/25/2009 | CA2709068A1 Benzofuran anilide histone deacetylase inhibitors |
| 06/25/2009 | CA2708866A1 Bicyclic heterocyclic derivative |
| 06/25/2009 | CA2708791A1 Novel imidazole-substituted arylamides |
| 06/25/2009 | CA2708786A1 Therapeutic uses of compounds having affinity to the serotonin transporter, serotonin receptors and noradrenalin transporter |
| 06/25/2009 | CA2708785A1 4-[2,3-difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine |
| 06/25/2009 | CA2707988A1 Novel pyrazole-substituted arylamides |
| 06/24/2009 | EP2072522A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 06/24/2009 | EP2072502A1 Sulfoximide substituted chinolin and chinazolin derivatives as kinase inhibitors |
| 06/24/2009 | EP2072082A2 N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3 sulfonamide as analgetic agent |
| 06/24/2009 | EP2072055A1 Composition and method for prevention and treatment of Alzheimer's disease |
| 06/24/2009 | EP1954698B1 Spirocyclic compounds as hdac inhibitors |
| 06/24/2009 | EP1781614B1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 06/24/2009 | EP1611109A4 Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 06/24/2009 | EP1483247B1 Aryl substituted pyrimidines and the use thereof |
| 06/24/2009 | EP1445258B1 Activator for peroxisome proliferator-activated receptor delta |
| 06/24/2009 | EP1339709B1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 06/24/2009 | EP1224861B1 Test method relating to adipose cells and to obesity by using a human h-pgds overexpressing non-human animal |
| 06/24/2009 | CN101461804A (+)-1-(3,4-dichlorrophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 06/24/2009 | CN100503638C Protein tau |
| 06/24/2009 | CN100503637C Glucagon-like peptide analog, its composition and its using method |
| 06/24/2009 | CN100503609C 2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine a2a receptor antagonists |
| 06/24/2009 | CN100503608C Deazapurines and uses thereof |
| 06/24/2009 | CN100503602C Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503574C Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 06/24/2009 | CN100503572C Caspase inhibitors and uses thereof |
| 06/24/2009 | CN100503570C Cyanoguanidine prodrugs |
| 06/24/2009 | CN100503566C Inhibitors of cytosolic phospholipase A2 |
| 06/24/2009 | CN100503562C Pyrrolidone derivatives as MAOB inhibitors |
| 06/24/2009 | CN100502903C Anshenning dripping pill for treating neurosism and its preparing method |
| 06/24/2009 | CN100502902C Honeysuckle and baical skullcap root combination, oral preparation and injection preparation containing same, its preparing method and application |
| 06/24/2009 | CN100502893C Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 06/24/2009 | CN100502884C Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/24/2009 | CN100502871C Use of barbituric acid derivatives in preparation for medicament of treating movement disorders |
| 06/24/2009 | CN100502863C 2,4,5-trisubstituded thiazolyl derivatives and their anti-inflammatory activity |
| 06/24/2009 | CN100502856C Treatment of dyskinesia |
| 06/23/2009 | US7550628 Process for preparing phenolic acid salts of gabapentin |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | US7550469 Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 06/23/2009 | US7550459 Neurodegenerative diseases, psychological disorders; e.g. 4-[3-(3a -Cyclopropylmethoxy-8-azabicyclo[3.2.1]oct-8-yl)-2-methylpropyl]-4H-benzo[1.4]oxazin-3-one |
| 06/23/2009 | US7550454 Analogs of clozapine; use with other neuropsychiatric agents; depression, anxiety, bipolar disorder, psychoses secondary to Alzheimer's or Huntington's disease; e.g. 2,7-Dichloro-11-(piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine |
| 06/23/2009 | US7550144 Antibody capable of reacting with cellular prion protein (PrP) ; for prevention of prion replication; for treatment or prevention of neuropathology such as Creutzfeldt-Jacob Disease |
| 06/23/2009 | US7550142 Anti-integrin antibodies, compositions, methods and uses |
| 06/23/2009 | CA2522220C Cgrp receptor antagonists |
| 06/23/2009 | CA2492804C Novel inhibitors of kinases |
| 06/23/2009 | CA2453917C Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient |
| 06/23/2009 | CA2449874C New indole derivatives with 5-ht6 receptor affinity |